Effect of nifedipine on renal allograft function and survival beyond one year

Clinical Nephrology

Volumn 47, Issue 1, 1997, Pages 33-36

  Shin, G T ^a   Cheigh, J S ^a,b   Riggio, R R ^a   Suthanthiran, M ^a   Stubenbord, W T ^a   Serur, D ^a   Wang, J C L ^a   Rubin, A L ^a   Stenzel, K H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Allograft function and survival; Nifedipine; Renal transplantation

Indexed keywords

CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; NIFEDIPINE;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; NIFEDIPINE; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031017427     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS 1993 Risk Factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-757
2. Birx DL, Berger M, Fleisher TA 1984 The interference of T cell activation by calcium channel blocking agents J Immunol 133: 2904-2909
3. Burke JF, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, Van Buren DH, West JC 1994 Long term efficacy and safety of cyclosporine in renal transplant recipients. N Engl J Med 331: 358-363
4. Carmines PK, Navar G 1989 Disparate effects of calcium channel blockade on afferent and efferent arteriolar responses to angiotensin II. Am J Physiol 256: F1015-F1020
5. Delmonico FL, Conti D, Auchincloss Jr H, Russel PS, Tolkoff-Rubin N, Fang LT, Cosimi B 1990 Long-term, low dose cyclosporine treatment of renal allograft recipients. Transplantation 49: 899-904
6. Eid A, Perkins JD, Rakela J, Krom RAF 1989 Conversion from standard cyclosporine to low dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year. Transplant Proc 21: 2238-2239
7. European multicenter trial group 1995 Cyclosporine in cadaveric renal transplantation: 10-year follow up of a multicenter trial. Transplantation 59: 1568-1570
8. Henricsson S, Lindholm A 1988 Inhibition of cyclosporine metabolism by other drugs in vitro. Transplant Proc 20 (Suppl 2): 569-571
9. Loutzenhiser R, Horton C, Sonke P, Epstein M 1985 Reversal of prostaglandin induced vasoconstriction by diltiazem: Studies in isolat- ed smooth muscle and perfused rat kidney. Kidney Int 27: 296 (abstr)
10. Loutzenhiser R, Epstein M 1990 Renal microvascular actions of calcium antagonists. J Am Soc Nephrol 1: S3-S12
11. Mcmillen MA, Lewis T, Jaffe BM, Wait RB 1985 Verapamil inhibition of lymphocyte proliferation and function in vitro. J Surg Research 39: 76-80
12. Morales JM, Andres A, Rodriguez PE, Paternina ER, Montoyo AC, Rodicio JL 1992 Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation. Transplant proc 24: 89-91
13. Neumayer HH, Kuzendorf U, Schreiber M 1992 Protective effects of calcium antagonists in human renal transplantation. Kidney Int 41 (Suppl 36): S87-S93
14. Nicholson ML, Dennis MJS, Beckingham IJ, Smith SJ 1993 Effect of nifedipine on renal transplant rejection. Br J Surg 80: 1318-1321
15. Pirsch JD, D'Alessandro AM, Roecker EB, Knechtle SJ, Reed A, Sollinger HW, Kalayoglu M, Belzer FO 1992 A controlled, Doubleblind, randomized trial of verapamil and CyA in cadaver renal transplant patients. Am J Kidney Dis 21: 189-195
16. Ponticelli C, Montagnino G, Aroldi A, Angelini C, Braga M, Tarantino A 1993 Hypertension after renal transplantation. Am J Kidney Dis 21 (suppl 2): 73-78
17. Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G 1993 Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion Kidney Int 43: 706-711
18. Sumrani N, Cacciarelli TV, Georgi B, Daskalakis P, Miles AM, Goldberg K, Hong JH, Sommer BG 1993 Contribution of acute rejection to renal allograft loss from chronic rejection. Transplant Proc 25: 2259-2260
19. Suthanthiran M, Haschemayer RH, Riggio RR, Adubor C, Friedman GS, Cheigh JS, Wang JC, Fontino M, Stubenbord WT, Saal SD, Stenzel KH, Rubin AL 1993 Excellent outcome with a calcium channel blocker supplemented immunosuppressive regimen in cadaveric renal transplantation. Transplantation 55: 1008-1013
20. Versluis DJ, Wenting GJ, Derkx FHM; Schalekamp MADH, Jeekel J, Weimar W 1987 Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation and why. Transplanation 44: 387-389
21. Weir MR, Suthanthiran M 1994 Supplementation of immunosuppressive regimens with calcium channel blockers. Clin Immunother 2: 458-467